Academic Content and Language Evaluation of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13711)
All Articles published online
|
Publishing Process of This Article
|
Aug 21, 2014 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tang SC, Chen YC. Novel therapeutic targets for pancreatic cancer. World J Gastroenterol 2014; 20(31): 10825-10844 [PMID: 25152585 DOI: 10.3748/wjg.v20.i31.10825] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i31/10825.htm |
| Number | Citing Articles |
| 1 |
David Witte, Franziska Zeeh, Thomas Gädeken, Frank Gieseler, Bernhard Rauch, Utz Settmacher, Roland Kaufmann, Hendrik Lehnert, Hendrik Ungefroren. Proteinase-Activated Receptor 2 Is a Novel Regulator of TGF-β Signaling in Pancreatic Cancer. Journal of Clinical Medicine 2016; 5(12): 111 doi: 10.3390/jcm5120111
|
| 2 |
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. The phytochemical p-hydroxycinnamic acid suppresses the growth and stimulates the death in human liver cancer HepG2 cells. Anti-Cancer Drugs 2021; 32(5): 558 doi: 10.1097/CAD.0000000000001059
|
| 3 |
Masayoshi Yamaguchi, Tomiyasu Murata. Extracellular regucalcin suppresses colony formation and growth independent of tumor suppressor p53 in human mammary epithelial cells. Tissue and Cell 2020; 67: 101447 doi: 10.1016/j.tice.2020.101447
|
| 4 |
MASAYOSHI YAMAGUCHI, SATORU OSUKA, M. NEALE WEITZMANN, BASSEL F. EL-RAYES, MAMORU SHOJI, TOMIYASU MURATA. Prolonged survival in pancreatic cancer patients with increased regucalcin gene expression: Overexpression of regucalcin suppresses the proliferation in human pancreatic cancer MIA PaCa-2 cells in vitro. International Journal of Oncology 2016; 48(5): 1955 doi: 10.3892/ijo.2016.3409
|
| 5 |
Masayoshi Yamaguchi, Tomiyasu Murata. Potential suppressive effects of gentian violet on human breast cancer MDA-MB-231 cells in vitro: Comparison with gemcitabine. Oncology Letters 2016; 12(2): 1605 doi: 10.3892/ol.2016.4773
|
| 6 |
J.C. Hunter, N.S. Gray, K.D. Westover. Conquering RAS. 2017; : 155 doi: 10.1016/B978-0-12-803505-4.00009-6
|
| 7 |
Tasuku Matsuoka, Masakazu Yashiro. Molecular targets for the treatment of pancreatic cancer: Clinical and experimental studies. World Journal of Gastroenterology 2016; 22(2): 776-789 doi: 10.3748/wjg.v22.i2.776
|
| 8 |
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA, BASSEL F. EL-RAYES, MAMORU SHOJI. The flavonoid p-hydroxycinnamic acid exhibits anticancer effects in human pancreatic cancer MIA PaCa-2 cells in vitro: Comparison with gemcitabine. Oncology Reports 2015; 34(6): 3304 doi: 10.3892/or.2015.4282
|
| 9 |
Masayoshi Yamaguchi. The botanical molecule p-hydroxycinnamic acid as a new osteogenic agent: insight into the treatment of cancer bone metastases. Molecular and Cellular Biochemistry 2016; 421(1-2): 193 doi: 10.1007/s11010-016-2803-1
|
| 10 |
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. The overexpressed regucalcin represses the growth via regulating diverse pathways linked to EGF signaling in human ovarian cancer SK-OV-3 cells: Involvement of extracellular regucalcin. Life Sciences 2023; 314: 121328 doi: 10.1016/j.lfs.2022.121328
|
| 11 |
Dejun Yang, Jian Shi, Hongbing Fu, Ziran Wei, Jiapeng Xu, Zunqi Hu, Yu Zhang, Ronglin Yan, Qingping Cai. Integrinβ1 modulates tumour resistance to gemcitabine and serves as an independent prognostic factor in pancreatic adenocarcinomas. Tumor Biology 2016; 37(9): 12315 doi: 10.1007/s13277-016-5061-7
|
| 12 |
Masayoshi Yamaguchi, Satoru Osuka, Tomiyasu Murata. Prolonged survival of patients with colorectal cancer is associated with a higher regucalcin gene expression: Overexpression of regucalcin suppresses the growth of human colorectal carcinoma cells in�vitro. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4458
|
| 13 |
Hendrik Ungefroren, David Witte, Bernhard Rauch, Utz Settmacher, Hendrik Lehnert, Frank Gieseler, Roland Kaufmann. Proteinase-Activated Receptor 2 May Drive Cancer Progression by Facilitating TGF-β Signaling. International Journal of Molecular Sciences 2017; 18(11): 2494 doi: 10.3390/ijms18112494
|
| 14 |
Kimberly M. Arnold, Lynn M. Opdenaker, Daniel Flynn, Jennifer Sims-Mourtada. Wound Healing and Cancer Stem Cells: Inflammation as a Driver of Treatment Resistance in Breast Cancer. Cancer Growth and Metastasis 2015; 8: CGM.S11286 doi: 10.4137/CGM.S11286
|
| 15 |
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA, MAMORU SHOJI, M. NEALE WEITZMANN. The flavonoid p-hydroxycinnamic acid mediates anticancer effects on MDA-MB-231 human breast cancer cells in vitro: Implications for suppression of bone metastases. International Journal of Oncology 2015; 47(4): 1563 doi: 10.3892/ijo.2015.3106
|
| 16 |
Zongchang Song, Wenying Liu, Yu Xiao, Minghui Zhang, Yan Luo, Weiwei Yuan, Yu Xu, Guanzhen Yu, Yide Hu, Keping Xie. PRR11 Is a Prognostic Marker and Potential Oncogene in Patients with Gastric Cancer. PLOS ONE 2015; 10(8): e0128943 doi: 10.1371/journal.pone.0128943
|
| 17 |
Masayoshi Yamaguchi, Satoru Osuka, M. Neale Weitzmann, Bassel F. El-Rayes, Mamoru Shoji, Tomiyasu Murata. Prolonged survival in hepatocarcinoma patients with increased regucalcin gene expression: HepG2 cell proliferation is suppressed by overexpression of regucalcin in vitro. International Journal of Oncology 2016; 49(4): 1686 doi: 10.3892/ijo.2016.3669
|
| 18 |
Masayoshi Yamaguchi. Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy. Cancers 2023; 15(22): 5489 doi: 10.3390/cancers15225489
|
| 19 |
S Calabretta, P Bielli, I Passacantilli, E Pilozzi, V Fendrich, G Capurso, G Delle Fave, C Sette. Modulation of PKM alternative splicing by PTBP1 promotes gemcitabine resistance in pancreatic cancer cells. Oncogene 2016; 35(16): 2031 doi: 10.1038/onc.2015.270
|
| 20 |
Masayoshi Yamaguchi, Satoru Osuka, Mamoru Shoji, M. Neale Weitzmann, Tomiyasu Murata. Survival of lung cancer patients is prolonged with higher regucalcin gene expression: suppressed proliferation of lung adenocarcinoma A549 cells in vitro. Molecular and Cellular Biochemistry 2017; 430(1-2): 37 doi: 10.1007/s11010-017-2952-x
|
| 21 |
Jianmin Wang, Antonios Papanicolau-Sengos, Sreenivasulu Chintala, Lei Wei, Biao Liu, Qiang Hu, Kiersten Marie Miles, Jeffrey M. Conroy, Sean T. Glenn, Manuela Costantini, Cristina Magi-Galluzzi, Sabina Signoretti, Toni Choueiri, Michele Gallucci, Steno Sentinelli, Vito M. Fazio, Maria Luana Poeta, Song Liu, Carl Morrison, Roberto Pili. Collecting duct carcinoma of the kidney is associated withCDKN2Adeletion andSLCfamily gene up-regulation. Oncotarget 2016; 7(21): 29901 doi: 10.18632/oncotarget.9093
|
| 22 |
Malgorzata Sztiller-Sikorska, Malgorzata Czyz. Parthenolide as Cooperating Agent for Anti-Cancer Treatment of Various Malignancies. Pharmaceuticals 2020; 13(8): 194 doi: 10.3390/ph13080194
|
| 23 |
Ebrahim Razi, Mehran Radak, Maryam Mahjoubin-Tehran, Samaneh Talebi, Alimohammad Shafiee, Sarah Hajighadimi, Sanaz Moradizarmehri, Hossein Sharifi, Nousin Mousavi, Mostafa Sarvizadeh, Majid Nejati, Mohsen Taghizadeh, Faezeh Ghasemi. Cancer stem cells as therapeutic targets of pancreatic cancer. Fundamental & Clinical Pharmacology 2020; 34(2): 202 doi: 10.1111/fcp.12521
|
| 24 |
Sarojamma Vemula, Manoj K. Gupta, Venkat R. Arva Tatireddygari, Ramakrishna Vadde. Theranostic Approach for Pancreatic Cancer. 2019; : 245 doi: 10.1016/B978-0-12-819457-7.00012-8
|
| 25 |
Jia‐Qiang Zhang, Shi Chen, Jiang‐Ning Gu, Yi Zhu, Qian Zhan, Dong‐Feng Cheng, Hao Chen, Xia‐Xing Deng, Bai‐Yong Shen, Cheng‐Hong Peng. Retracted: MicroRNA‐300 promotes apoptosis and inhibits proliferation, migration, invasion and epithelial‐mesenchymal transition via the Wnt/β‐catenin signaling pathway by targeting CUL4B in pancreatic cancer cells. Journal of Cellular Biochemistry 2018; 119(1): 1027 doi: 10.1002/jcb.26270
|
| 26 |
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. Extracellular Regucalcin Suppresses the Growth, Migration, Invasion, and Adhesion of Metastatic Human Prostate Cancer Cells. Oncology 2022; 100(7): 399 doi: 10.1159/000524303
|
| 27 |
Ahmad Abu Turab Naqvi, Gulam Mustafa Hasan, Md Imtaiyaz Hassan. Investigating the role of transcription factors of pancreas development in pancreatic cancer. Pancreatology 2018; 18(2): 184 doi: 10.1016/j.pan.2017.12.013
|
| 28 |
Eri Yoshida, Daisuke Kudo, Hayato Nagase, Hiroshi Shimoda, Shinichiro Suto, Mika Negishi, Ikuko Kakizaki, Masahiko Endo, Kenichi Hakamada. Antitumor effects of the hyaluronan inhibitor 4-methylumbelliferone on pancreatic cancer. Oncology Letters 2016; 12(4): 2337 doi: 10.3892/ol.2016.4930
|
| 29 |
Masayoshi Yamaguchi, Satoru Osuka, Oliver Hankinson, Tomiyasu Murata. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4611
|
| 30 |
Ganji Purnachandra Nagaraju, Leah Benton, Shipra Reddy Bethi, Mamoru Shoji, Bassel F. El‐Rayes. Curcumin analogs: Their roles in pancreatic cancer growth and metastasis. International Journal of Cancer 2019; 145(1): 10 doi: 10.1002/ijc.31867
|
| 31 |
Noemi Garcia-Romero, Susana Esteban-Rubio, Gorjana Rackov, Josefa Carrión-Navarro, Cristobal Belda-Iniesta, Angel Ayuso-Sacido. Extracellular vesicles compartment in liquid biopsies: Clinical application. Molecular Aspects of Medicine 2018; 60: 27 doi: 10.1016/j.mam.2017.11.009
|
| 32 |
Sheng Chen, Ye Wang, Wen-Long Zhang, Mao-Sheng Dong, Jian-Hua Zhang. Sclareolide enhances gemcitabine-induced cell death through mediating the NICD and Gli1 pathways in gemcitabine-resistant human pancreatic cancer. Molecular Medicine Reports 2017; 15(4): 1461 doi: 10.3892/mmr.2017.6182
|
| 33 |
Yanhui Lou, Huanhuan Jiang, Zhumei Cui, Xiangyu Wang, Lingzhi Wang, Yi Han. Gene microarray analysis of lncRNA and mRNA expression profiles in patients with high‑grade ovarian serous cancer. International Journal of Molecular Medicine 2018; doi: 10.3892/ijmm.2018.3588
|
| 34 |
Hang Yin, ShaoPeng Wang, Yu-Hang Zhang, Yu-Dong Cai, Hailin Liu. Analysis of Important Gene Ontology Terms and Biological Pathways Related to Pancreatic Cancer. BioMed Research International 2016; 2016: 1 doi: 10.1155/2016/7861274
|
| 35 |
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA. Suppressive effects of exogenous regucalcin on the proliferation of human pancreatic cancer MIA PaCa-2 cells in vitro. International Journal of Molecular Medicine 2015; 35(6): 1773 doi: 10.3892/ijmm.2015.2164
|
| 36 |
Guang Tan, Bing Li, YiJun Zhang, RengYin Zhang, Lin Wang, Fengjun Liu, Fei Shan. Targeted Fluorescence Imaging and Anti-Tumor Effects of QDs-NGR Nanoparticles on Pancreatic Cancer Cells. Science of Advanced Materials 2021; 13(12): 2475 doi: 10.1166/sam.2021.4163
|
| 37 |
Cui-Juan Qian, Yi-Yi Chen, Xin Zhang, Fu-Qiang Liu, Ting-Ting Yue, Bei Ye, Jun Yao. Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells. Oncology Letters 2016; 12(5): 3499 doi: 10.3892/ol.2016.5097
|
| 38 |
Md. Faiz Ahmad, Sarah E. Huff, John Pink, Intekhab Alam, Andrew Zhang, Kay Perry, Michael E. Harris, Tessianna Misko, Suheel K. Porwal, Nancy L. Oleinick, Masaru Miyagi, Rajesh Viswanathan, Chris Godfrey Dealwis. Identification of Non-nucleoside Human Ribonucleotide Reductase Modulators. Journal of Medicinal Chemistry 2015; 58(24): 9498 doi: 10.1021/acs.jmedchem.5b00929
|
| 39 |
Gebremariam Birhanu, Hamid Akbari Javar, Ehsan Seyedjafari, Ali Zandi-Karimi. Nanotechnology for delivery of gemcitabine to treat pancreatic cancer. Biomedicine & Pharmacotherapy 2017; 88: 635 doi: 10.1016/j.biopha.2017.01.071
|
| 40 |
Kaiwei Xu, Lufei Jin, Liu Xu, Yuchao Zhu, Lu Hong, Chunshu Pan, Yanying Li, Junlie Yao, Ruifen Zou, Weiwei Tang, Jianhua Wang, Aiguo Wu, Wenzhi Ren. IGF1 receptor-targeted black TiO2 nanoprobes for MRI-guided synergetic photothermal-chemotherapy in drug resistant pancreatic tumor. Journal of Nanobiotechnology 2022; 20(1) doi: 10.1186/s12951-022-01525-3
|
| 41 |
MASAYOSHI YAMAGUCHI, TOMIYASU MURATA. Exogenous regucalcin suppresses the proliferation of human breast cancer MDA-MB-231 bone metastatic cells in vitro. Molecular Medicine Reports 2015; 12(5): 7801 doi: 10.3892/mmr.2015.4352
|
| 42 |
Masayoshi Yamaguchi, Tomiyasu Murata, Joe W. Ramos. The botanical component p-hydroxycinnamic acid suppresses the growth and bone metastatic activity of human prostate cancer PC-3 cells in vitro. Journal of Cancer Research and Clinical Oncology 2021; 147(2): 339 doi: 10.1007/s00432-020-03405-5
|
| 43 |
Masayoshi Yamaguchi, Satoru Osuka, M. Neale Weitzmann, Mamoru Shoji, Tomiyasu Murata. Increased regucalcin gene expression extends survival in breast cancer patients: Overexpression of regucalcin suppresses the proliferation and metastatic bone activity in MDA-MB-231 human breast cancer cells in vitro. International Journal of Oncology 2016; 49(2): 812 doi: 10.3892/ijo.2016.3538
|
| 44 |
Masayoshi Yamaguchi, Oliver Hankinson. 2,3,7,8‑Tetrachlorodibenzo‑p‑dioxin suppresses the growth of human liver cancer HepG2 cells in vitro: Involvement of cell signaling factors. International Journal of Oncology 2018; doi: 10.3892/ijo.2018.4507
|
| 45 |
Masayoshi Yamaguchi, Kenji Yosiike, Hideaki Watanabe, Mitsugu Watanabe. The marine factor 3,5-dihydroxy-4-methoxybenzyl alcohol suppresses growth, migration and invasion and stimulates death of metastatic human prostate cancer cells: targeting diverse signaling processes. Anti-Cancer Drugs 2022; 33(5): 424 doi: 10.1097/CAD.0000000000001306
|
| 46 |
Zhe Ma, Fan Chao, Shiyu Wang, Zhenyu Song, Zhiyuan Zhuo, Jinguo Zhang, Guoxiong Xu, Gang Chen. CTHRC1 affects malignant tumor cell behavior and is regulated by miR-30e-5p in human prostate cancer. Biochemical and Biophysical Research Communications 2020; 525(2): 418 doi: 10.1016/j.bbrc.2020.02.098
|
| 47 |
Wenying Yan, Xingyi Liu, Yibo Wang, Shuqing Han, Fan Wang, Xin Liu, Fei Xiao, Guang Hu. Identifying Drug Targets in Pancreatic Ductal Adenocarcinoma Through Machine Learning, Analyzing Biomolecular Networks, and Structural Modeling. Frontiers in Pharmacology 2020; 11 doi: 10.3389/fphar.2020.00534
|
| 48 |
Zhen Yu, Ze Yu, ZhenBao Chen, Lin Yang, MingJun Ma, ShouNan Lu, ChunSheng Wang, ChunBo Teng, YuZhe Nie. Zinc chelator TPEN induces pancreatic cancer cell death through causing oxidative stress and inhibiting cell autophagy. Journal of Cellular Physiology 2019; 234(11): 20648 doi: 10.1002/jcp.28670
|
| 49 |
Molecular Processes Involved in Pancreatic Cancer and Therapeutics. Current Chemical Biology 2021; 15(1): 85 doi: 10.2174/2212796814999201008130819
|
| 50 |
Wei Xiong, Wen-Hui Li, Yong-Xin Jiang, Shan Liu, Yi-Qin Ai, Rong Liu, Li Chang, Ming Zhang, Xiao-Li Wang, Han Bai, Hong Wang, Rui Zheng, Jing Tan. Parecoxib: an Enhancer of Radiation Therapy for Colorectal Cancer. Asian Pacific Journal of Cancer Prevention 2015; 16(2): 627 doi: 10.7314/APJCP.2015.16.2.627
|
| 51 |
Minzhi Hou, Zhiqiang Cheng, Hongwei Shen, Shanyang He, Yang Li, Yunping Pan, Chongjin Feng, Xinlin Chen, Yang Zhang, Millicent Lin, Liantang Wang, Zunfu Ke. High expression of CTHRC1 promotes EMT of epithelial ovarian cancer (EOC) and is associated with poor prognosis. Oncotarget 2015; 6(34): 35813 doi: 10.18632/oncotarget.5358
|
| 52 |
Masayoshi Yamaguchi, Tomiyasu Murata. Overexpression of Regucalcin Suppresses the Growth of Human Osteosarcoma Cells in Vitro: Repressive Effect of Extracellular Regucalcin. Cancer Investigation 2020; 38(1): 37 doi: 10.1080/07357907.2019.1708924
|
| 53 |
Omeima Abdullah, Ziad Omran, Salman Hosawi, Ali Hamiche, Christian Bronner, Mahmoud Alhosin. Thymoquinone Is a Multitarget Single Epidrug That Inhibits the UHRF1 Protein Complex. Genes 2021; 12(5): 622 doi: 10.3390/genes12050622
|
| 54 |
Julia Baguña Torres, James C. Knight, Michael J. Mosley, Veerle Kersemans, Sofia Koustoulidou, Danny Allen, Paul Kinchesh, Sean Smart, Bart Cornelissen. Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody. Molecular Imaging and Biology 2018; 20(2): 292 doi: 10.1007/s11307-017-1112-8
|
| 55 |
Chang Liu, Jin-Ou Wang, Wen-Yang Zhou, Xiao-Ying Chang, Ming-Ming Zhang, Ying Zhang, Xiang-Hong Yang. Long non-coding RNA LINC01207 silencing suppresses AGR2 expression to facilitate autophagy and apoptosis of pancreatic cancer cells by sponging miR-143-5p. Molecular and Cellular Endocrinology 2019; 493: 110424 doi: 10.1016/j.mce.2019.04.004
|
| 56 |
Sarah E. Huff, Jordan M. Winter, Chris G. Dealwis. Inhibitors of the Cancer Target Ribonucleotide Reductase, Past and Present. Biomolecules 2022; 12(6): 815 doi: 10.3390/biom12060815
|
| 57 |
Yu-Jie Zhou, Gui-Qi Zhu, Qing-Wei Zhang, Kenneth I. Zheng, Jin-Nan Chen, Xin-Tian Zhang, Qi-Wen Wang, Xiao-Bo Li. Survival-Associated Alternative Messenger RNA Splicing Signatures in Pancreatic Ductal Adenocarcinoma: A Study Based on RNA-Sequencing Data. DNA and Cell Biology 2019; 38(11): 1207 doi: 10.1089/dna.2019.4862
|